Thomas Berg - Concepedia

Author

Thomas Berg

Charité - Universitätsmedizin Berlin ORCID

Also Known As

Berg, T, Berg, Thomas, C Trepo, Eleonora De Martin, Flisiak, Robert, Golo Ahlenstiel, Guido Gerken, Johann Pratschke, K Hamesch, M. Reiser

1.6K

Publications

55.2K

Citations

109

H-Index

229

Concepts

All Affiliations

Charité - Universitätsmedizin Berlin University Hospital Leipzig Goethe University Frankfurt Medizinische Hochschule Hannover Leipzig University

About

Thomas Berg is an author at Charité - Universitätsmedizin Berlin specializing in medicine, hepatology, and hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	67	201	22.2K
2	Health Sciences	16	19	1.4K
3	Public Health	13	14	1.8K
4	Natural Sciences	7	7	453
5	Engineering	2	2	78

Thomas Berg

467

Publications

45K

Citations

H-Index

Page 1

	Year	Citations
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection Pietro Lampertico, Kosh Agarwal, Thomas Berg, Journal of Hepatology Hepatitis DViral HepatitisHepatitis BHepatitisAntiviral Therapy	2017	5.3K
Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B George Lau, Teerha Piratvisuth, Kang Luo, New England Journal of Medicine	2005	1.5K
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial Zobair M. Younossi, Vlad Ratziu, Rohit Loomba, The Lancet Interim AnalysisMetabolic Associated SteatohepatitisHepatologyPlacebo-controlled Phase 3Nonalcoholic Fatty Liver Disease	2019	1.2K
Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study Andri Rauch, Zoltán Kutalik, Patrick Descombes, Gastroenterology Genome-wide Association StudyDisease SusceptibilityIl28b Is AssociatedAutoimmune DiseaseHepatitis C	2010	1.1K
Vascular Invasion and Histopathologic Grading Determine Outcome After Liver Transplantation for Hepatocellular Carcinoma in Cirrhosis Sven Jonas, Wolf O. Bechstein, Thomas Steinmüller, Hepatology	2001	903
ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis Fred Poordad, Christophe Hézode, Roger Trinh, New England Journal of Medicine	2014	872
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection Graham R. Foster, Nezam H. Afdhal, Stuart K. Roberts, New England Journal of Medicine	2015	845
A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis Stephan Buch, Felix Stickel, Eric Trépo, Nature Genetics Genome-wide Association StudyHepatologyMedicineLiver PhysiologyGenetics	2015	543
Extended Treatment Duration for Hepatitis C Virus Type 1: Comparing 48 Versus 72 Weeks of Peginterferon-Alfa-2a Plus Ribavirin Thomas Berg, Michael Wagner, Samer Nasser, Gastroenterology Peginterferon-alfa-2a Plus RibavirinHepatologyHepatitis CVersus 72Viral Hepatitis	2006	519
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm Homie Razavi, Imam Waked, Christoph Sarrazin, Journal of Viral Hepatitis	2014	484

Page 1